Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1.

Kleemann R, Hausser A, Geiger G, Mischke R, Burger-Kentischer A, Flieger O, Johannes FJ, Roger T, Calandra T, Kapurniotu A, Grell M, Finkelmeier D, Brunner H, Bernhagen J.

Nature. 2000 Nov 9;408(6809):211-6.

PMID:
11089976
2.

Thioredoxin modulates activator protein 1 (AP-1) activity and p27Kip1 degradation through direct interaction with Jab1.

Hwang CY, Ryu YS, Chung MS, Kim KD, Park SS, Chae SK, Chae HZ, Kwon KS.

Oncogene. 2004 Nov 25;23(55):8868-75.

PMID:
15480426
3.

A 16-residue peptide fragment of macrophage migration inhibitory factor, MIF-(50-65), exhibits redox activity and has MIF-like biological functions.

Nguyen MT, Beck J, Lue H, Fünfzig H, Kleemann R, Koolwijk P, Kapurniotu A, Bernhagen J.

J Biol Chem. 2003 Sep 5;278(36):33654-71. Epub 2003 Jun 9.

4.
5.

Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1.

Tomoda K, Kubota Y, Kato J.

Nature. 1999 Mar 11;398(6723):160-5.

PMID:
10086358
6.

The cytoplasmic shuttling and subsequent degradation of p27Kip1 mediated by Jab1/CSN5 and the COP9 signalosome complex.

Tomoda K, Kubota Y, Arata Y, Mori S, Maeda M, Tanaka T, Yoshida M, Yoneda-Kato N, Kato JY.

J Biol Chem. 2002 Jan 18;277(3):2302-10. Epub 2001 Nov 9.

7.

Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity.

Lue H, Thiele M, Franz J, Dahl E, Speckgens S, Leng L, Fingerle-Rowson G, Bucala R, Lüscher B, Bernhagen J.

Oncogene. 2007 Aug 2;26(35):5046-59. Epub 2007 Feb 19.

PMID:
17310986
8.

The Jab1/COP9 signalosome subcomplex is a downstream mediator of Bcr-Abl kinase activity and facilitates cell-cycle progression.

Tomoda K, Kato JY, Tatsumi E, Takahashi T, Matsuo Y, Yoneda-Kato N.

Blood. 2005 Jan 15;105(2):775-83. Epub 2004 Sep 7.

9.

Rapid and transient activation of the ERK MAPK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on JAB1/CSN5 and Src kinase activity.

Lue H, Kapurniotu A, Fingerle-Rowson G, Roger T, Leng L, Thiele M, Calandra T, Bucala R, Bernhagen J.

Cell Signal. 2006 May;18(5):688-703. Epub 2005 Aug 24.

PMID:
16122907
10.

Adapter protein NRBP associates with Jab1 and negatively regulates AP-1 activity.

Wang H, Sun X, Luo Y, Lin Z, Wu J.

FEBS Lett. 2006 Oct 30;580(25):6015-21. Epub 2006 Oct 12.

11.

Jab1 co-activation of c-Jun is abrogated by the serine 10-phosphorylated form of p27Kip1.

Chopra S, Fernandez De Mattos S, Lam EW, Mann DJ.

J Biol Chem. 2002 Sep 6;277(36):32413-6. Epub 2002 Jul 15.

14.

Intracrine hepatopoietin potentiates AP-1 activity through JAB1 independent of MAPK pathway.

Lu C, Li Y, Zhao Y, Xing G, Tang F, Wang Q, Sun Y, Wei H, Yang X, Wu C, Chen J, Guan KL, Zhang C, Chen H, He F.

FASEB J. 2002 Jan;16(1):90-2. Epub 2001 Nov 14.

PMID:
11709497
15.

Multiple functions of Jab1 are required for early embryonic development and growth potential in mice.

Tomoda K, Yoneda-Kato N, Fukumoto A, Yamanaka S, Kato JY.

J Biol Chem. 2004 Oct 8;279(41):43013-8. Epub 2004 Aug 6.

16.

A new group of conserved coactivators that increase the specificity of AP-1 transcription factors.

Claret FX, Hibi M, Dhut S, Toda T, Karin M.

Nature. 1996 Oct 3;383(6599):453-7.

PMID:
8837781
17.

The hepatitis B virus X protein enhances AP-1 activation through interaction with Jab1.

Tanaka Y, Kanai F, Ichimura T, Tateishi K, Asaoka Y, Guleng B, Jazag A, Ohta M, Imamura J, Ikenoue T, Ijichi H, Kawabe T, Isobe T, Omata M.

Oncogene. 2006 Jan 26;25(4):633-42.

PMID:
16247477
18.

Differentiation-associated expression and intracellular localization of cyclin-dependent kinase inhibitor p27KIP1 and c-Jun co-activator JAB1 in neuroblastoma.

Shen L, Tsuchida R, Miyauchi J, Saeki M, Honna T, Tsunematsu Y, Kato J, Mizutani S.

Int J Oncol. 2000 Oct;17(4):749-54.

PMID:
10995887
19.

Binding of JAB1/CSN5 to MIF is mediated by the MPN domain but is independent of the JAMM motif.

Burger-Kentischer A, Finkelmeier D, Thiele M, Schmucker J, Geiger G, Tovar GE, Bernhagen J.

FEBS Lett. 2005 Mar 14;579(7):1693-701.

20.

Prognostic significance of Jab1 expression in laryngeal squamous cell carcinomas.

Dong Y, Sui L, Watanabe Y, Yamaguchi F, Hatano N, Tokuda M.

Clin Cancer Res. 2005 Jan 1;11(1):259-66.

Supplemental Content

Support Center